THE TGA has issued five infringement notices totalling $66,600 to Affinity Corp Australia Pty Ltd for the alleged unlawful advertising of medicinal cannabis products.
The company allegedly promoted the use of unapproved prescription-only medicinal cannabis products, including their own products.
Businesses can only advertise prescription-only medicines exclusively to health professionals and not to the public, the TGA explained.
The TGA said it facilitates legal pathways for doctors to prescribe medicinal cannabis products to patients.
Advertising of prescription-only medicines directly to consumers undermines the doctor-patient relationship and may create an inappropriate demand for medicines which may not be right for the individual, stated the TGA.
Ensuring compliance with the import, advertising and supply requirements of medicinal cannabis is a priority, said the TGA.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Jun 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Jun 23
